Acebutolol
Ginkgo biloba may increase the bradycardic activities of Acebutolol.
Acenocoumarol
The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Acenocoumarol.
Acetyl salicylate
Ginkgo biloba may increase the anticoagulant activities of Acetylsalicylic acid.
Advertisement
Acetylcholine
The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Acetylcholine.
Acetylcholine Chloride
The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Acetylcholine.
Aclidinium
The therapeutic efficacy of Aclidinium can be decreased when used in combination with Ginkgo biloba.
Advertisement
Alclometasone
The risk or severity of adverse effects can be increased when Alclometasone is combined with Ginkgo biloba.
Aldosterone
The risk or severity of adverse effects can be increased when Aldosterone is combined with Ginkgo biloba.
Aloxiprin
Ginkgo biloba may increase the anticoagulant activities of Aloxiprin.
Advertisement
Alprenolol
Ginkgo biloba may increase the bradycardic activities of Alprenolol.
Amcinonide
The risk or severity of adverse effects can be increased when Amcinonide is combined with Ginkgo biloba.
Aminosalicylic Acid
Ginkgo biloba may increase the anticoagulant activities of Aminosalicylic Acid.
Androstenedione
The risk or severity of adverse effects can be increased when Androstenedione is combined with Ginkgo biloba.
Aspirin
Ginkgo biloba may increase the anticoagulant activities of Acetylsalicylic acid.
Atenolol
Ginkgo biloba may increase the bradycardic activities of Atenolol.
Atracurium
The therapeutic efficacy of Atracurium can be decreased when used in combination with Ginkgo biloba.
Atracurium Besylate
The therapeutic efficacy of Atracurium besylate can be decreased when used in combination with Ginkgo biloba.
Atropine
The therapeutic efficacy of Atropine can be decreased when used in combination with Ginkgo biloba.
Balsalazide
Ginkgo biloba may increase the anticoagulant activities of Balsalazide.
Beclomethasone Dipropionate
The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Ginkgo biloba.
Benactyzine
The therapeutic efficacy of Benactyzine can be decreased when used in combination with Ginkgo biloba.
Benztropine
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Ginkgo biloba.
Betamethasone
The risk or severity of adverse effects can be increased when Betamethasone is combined with Ginkgo biloba.
Betaxolol
Ginkgo biloba may increase the bradycardic activities of Betaxolol.
Bethanechol
The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Bethanechol.
Biperiden
The therapeutic efficacy of Biperiden can be decreased when used in combination with Ginkgo biloba.
Bisoprolol
Ginkgo biloba may increase the bradycardic activities of Bisoprolol.
Bopindolol
Ginkgo biloba may increase the bradycardic activities of Bopindolol.
Budesonide
The risk or severity of adverse effects can be increased when Budesonide is combined with Ginkgo biloba.
Bupranolol
Ginkgo biloba may increase the bradycardic activities of Bupranolol.
Butylscopolamine
The therapeutic efficacy of Butylscopolamine can be decreased when used in combination with Ginkgo biloba.
Carbachol
The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Carbachol.
Carteolol
Ginkgo biloba may increase the bradycardic activities of Carteolol.
Carvedilol
Ginkgo biloba may increase the bradycardic activities of Carvedilol.
Celiprolol
Ginkgo biloba may increase the bradycardic activities of Celiprolol.
Cevimeline
The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Cevimeline.
Chlorphenoxamine
The therapeutic efficacy of Chlorphenoxamine can be decreased when used in combination with Ginkgo biloba.
Ciclesonide
The risk or severity of adverse effects can be increased when Ciclesonide is combined with Ginkgo biloba.
Clobetasol
The risk or severity of adverse effects can be increased when Clobetasol is combined with Ginkgo biloba.
Clobetasol Propionate
The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Ginkgo biloba.
Clobetasone
The risk or severity of adverse effects can be increased when Clobetasone is combined with Ginkgo biloba.
Clocortolone
The risk or severity of adverse effects can be increased when Clocortolone is combined with Ginkgo biloba.
Cortisone Acetate
The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Ginkgo biloba.
Cyclopentolate
The therapeutic efficacy of Cyclopentolate can be decreased when used in combination with Ginkgo biloba.
Darifenacin
The therapeutic efficacy of Darifenacin can be decreased when used in combination with Ginkgo biloba.
Deflazacort
The risk or severity of adverse effects can be increased when Deflazacort is combined with Ginkgo biloba.
Desloratadine
The therapeutic efficacy of Desloratadine can be decreased when used in combination with Ginkgo biloba.
Desonide
The risk or severity of adverse effects can be increased when Desonide is combined with Ginkgo biloba.
Desoximetasone
The risk or severity of adverse effects can be increased when Desoximetasone is combined with Ginkgo biloba.
Desoxycorticosterone acetate
The risk or severity of adverse effects can be increased when Desoxycorticosterone acetate is combined with Ginkgo biloba.
Desoxycorticosterone Pivalate
The risk or severity of adverse effects can be increased when Desoxycorticosterone Pivalate is combined with Ginkgo biloba.
Dexamethasone
The risk or severity of adverse effects can be increased when Dexamethasone is combined with Ginkgo biloba.
Dexetimide
The therapeutic efficacy of Dexetimide can be decreased when used in combination with Ginkgo biloba.
Dicumarol
The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Dicoumarol.
Dicyclomine
The therapeutic efficacy of Dicyclomine can be decreased when used in combination with Ginkgo biloba.
Diflorasone
The risk or severity of adverse effects can be increased when Diflorasone is combined with Ginkgo biloba.
Diflucortolone
The risk or severity of adverse effects can be increased when Difluocortolone is combined with Ginkgo biloba.
Diflunisal
Ginkgo biloba may increase the anticoagulant activities of Diflunisal.
Difluprednate
The risk or severity of adverse effects can be increased when Difluprednate is combined with Ginkgo biloba.
Dipyridamole
The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Dipyridamole.
Efavirenz
The serum concentration of Efavirenz can be decreased when it is combined with Ginkgo biloba.
Esmolol
Ginkgo biloba may increase the bradycardic activities of Esmolol.
Estrone
The risk or severity of adverse effects can be increased when Estrone is combined with Ginkgo biloba.
Fesoterodine
The therapeutic efficacy of Fesoterodine can be decreased when used in combination with Ginkgo biloba.
Fludrocortisone
The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Ginkgo biloba.
Fluindione
The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Fluindione.
Flumethasone
The risk or severity of adverse effects can be increased when Flumethasone is combined with Ginkgo biloba.
Flunisolide
The risk or severity of adverse effects can be increased when Flunisolide is combined with Ginkgo biloba.
Flunisolide Anhydrous (obsolete)
The risk or severity of adverse effects can be increased when Flunisolide is combined with Ginkgo biloba.
Fluocinolone Acetonide
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Ginkgo biloba.
Fluocinonide
The risk or severity of adverse effects can be increased when Fluocinonide is combined with Ginkgo biloba.
Fluocortolone
The risk or severity of adverse effects can be increased when Fluocortolone is combined with Ginkgo biloba.
Fluorometholone
The risk or severity of adverse effects can be increased when Fluorometholone is combined with Ginkgo biloba.
FLUPREDNIDENE
The risk or severity of adverse effects can be increased when Fluprednidene is combined with Ginkgo biloba.
Fluprednisolone
The risk or severity of adverse effects can be increased when Fluprednisolone is combined with Ginkgo biloba.
Flurandrenolide
The risk or severity of adverse effects can be increased when Flurandrenolide is combined with Ginkgo biloba.
Fluticasone Furoate
The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Ginkgo biloba.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Ginkgo biloba.
Formestane
The risk or severity of adverse effects can be increased when Formestane is combined with Ginkgo biloba.
Gallamine Triethiodide
The therapeutic efficacy of Gallamine Triethiodide can be decreased when used in combination with Ginkgo biloba.
Glycopyrronium
The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Ginkgo biloba.
Halcinonide
The risk or severity of adverse effects can be increased when Halcinonide is combined with Ginkgo biloba.
Halobetasol
The risk or severity of adverse effects can be increased when Ulobetasol is combined with Ginkgo biloba.
Homatropine
The therapeutic efficacy of Homatropine can be decreased when used in combination with Ginkgo biloba.
Hydrocortisone
The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Ginkgo biloba.
Hyoscyamine
The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Ginkgo biloba.
Ipratropium Bromide
The therapeutic efficacy of Ipratropium bromide can be decreased when used in combination with Ginkgo biloba.
Ipratropium Bromide Anhydrous
The therapeutic efficacy of Ipratropium bromide can be decreased when used in combination with Ginkgo biloba.
Labetalol
Ginkgo biloba may increase the bradycardic activities of Labetalol.
Levobunolol
Ginkgo biloba may increase the bradycardic activities of Levobunolol.
Lobeline
The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Lobeline.
Loteprednol
The risk or severity of adverse effects can be increased when Loteprednol is combined with Ginkgo biloba.
Mecamylamine
The therapeutic efficacy of Mecamylamine can be decreased when used in combination with Ginkgo biloba.
Medrysone
The risk or severity of adverse effects can be increased when Medrysone is combined with Ginkgo biloba.
Mesalamine
Ginkgo biloba may increase the anticoagulant activities of Mesalazine.
Methacholine
The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Methacholine.
Methantheline
The therapeutic efficacy of Methantheline can be decreased when used in combination with Ginkgo biloba.
Methixene
The therapeutic efficacy of Metixene can be decreased when used in combination with Ginkgo biloba.
Methscopolamine Bromide
The therapeutic efficacy of Methylscopolamine bromide can be decreased when used in combination with Ginkgo biloba.
Methyl Salicylate
Ginkgo biloba may increase the anticoagulant activities of Methyl salicylate.
Methylprednisolone
The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Ginkgo biloba.
Metipranolol
Ginkgo biloba may increase the bradycardic activities of Metipranolol.
Metoprolol
Ginkgo biloba may increase the bradycardic activities of Metoprolol.
Midazolam
The serum concentration of Midazolam can be decreased when it is combined with Ginkgo biloba.
Mivacurium
Ginkgo biloba may decrease the neuromuscular blocking activities of Mivacurium.
Mometasone
The risk or severity of adverse effects can be increased when Mometasone is combined with Ginkgo biloba.
Nadolol
Ginkgo biloba may increase the bradycardic activities of Nadolol.
Nebivolol
Ginkgo biloba may increase the bradycardic activities of Nebivolol.
Nicotine
The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Nicotine.
Nicotine Polacrilex
The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Nicotine.
Octotropine Methylbromide
The therapeutic efficacy of Anisotropine Methylbromide can be decreased when used in combination with Ginkgo biloba.
Octylonium
The therapeutic efficacy of Otilonium can be decreased when used in combination with Ginkgo biloba.
Olsalazine
Ginkgo biloba may increase the anticoagulant activities of Olsalazine.
Orphenadrine
The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Ginkgo biloba.
Oxitropium
The therapeutic efficacy of Oxitropium can be decreased when used in combination with Ginkgo biloba.
Oxprenolol
Ginkgo biloba may increase the bradycardic activities of Oxprenolol.
Oxybutynin
The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Ginkgo biloba.
Oxyphenonium
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Ginkgo biloba.
Pancuronium
The therapeutic efficacy of Pancuronium can be decreased when used in combination with Ginkgo biloba.
Pancuronium Bromide
The therapeutic efficacy of Pancuronium can be decreased when used in combination with Ginkgo biloba.
Paramethasone
The risk or severity of adverse effects can be increased when Paramethasone is combined with Ginkgo biloba.
Penbutolol
Ginkgo biloba may increase the bradycardic activities of Penbutolol.
Phenindione
The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Phenindione.
Phenprocoumon
The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Phenprocoumon.
Pilocarpine
The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Pilocarpine.
Pindolol
Ginkgo biloba may increase the bradycardic activities of Pindolol.
Pipecuronium
The therapeutic efficacy of Pipecuronium can be decreased when used in combination with Ginkgo biloba.
Pirenzepine
The therapeutic efficacy of Pirenzepine can be decreased when used in combination with Ginkgo biloba.
Practolol
Ginkgo biloba may increase the bradycardic activities of Practolol.
Prasterone
The risk or severity of adverse effects can be increased when Prasterone is combined with Ginkgo biloba.
Prednicarbate
The risk or severity of adverse effects can be increased when Prednicarbate is combined with Ginkgo biloba.
Prednisolone
The risk or severity of adverse effects can be increased when Prednisolone is combined with Ginkgo biloba.
Prednisone
The risk or severity of adverse effects can be increased when Prednisone is combined with Ginkgo biloba.
Pregnenolone
The risk or severity of adverse effects can be increased when Pregnenolone is combined with Ginkgo biloba.
Procyclidine
The therapeutic efficacy of Procyclidine can be decreased when used in combination with Ginkgo biloba.
Profenamine
The therapeutic efficacy of Ethopropazine can be decreased when used in combination with Ginkgo biloba.
Propantheline
The therapeutic efficacy of Propantheline can be decreased when used in combination with Ginkgo biloba.
Propantheline Bromide
The therapeutic efficacy of Propantheline can be decreased when used in combination with Ginkgo biloba.
Propiverine
The therapeutic efficacy of Propiverine can be decreased when used in combination with Ginkgo biloba.
Propranolol
Ginkgo biloba may increase the bradycardic activities of Propranolol.
Quinidine
The therapeutic efficacy of Quinidine can be decreased when used in combination with Ginkgo biloba.
Rapacuronium
Ginkgo biloba may decrease the neuromuscular blocking activities of Rapacuronium.
Rimexolone
The risk or severity of adverse effects can be increased when Rimexolone is combined with Ginkgo biloba.
Salicylic Acid
Ginkgo biloba may increase the anticoagulant activities of Salicylic acid.
Scopolamine
The therapeutic efficacy of Scopolamine can be decreased when used in combination with Ginkgo biloba.
Scopolamine Hydrobromide
The therapeutic efficacy of Scopolamine can be decreased when used in combination with Ginkgo biloba.
Solifenacin
The therapeutic efficacy of Solifenacin can be decreased when used in combination with Ginkgo biloba.
Sotalol
Ginkgo biloba may increase the bradycardic activities of Sotalol.
Succinylcholine
The serum concentration of Succinylcholine can be increased when it is combined with Ginkgo biloba.
Talinolol
Ginkgo biloba may increase the bradycardic activities of Talinolol.
Timolol
Ginkgo biloba may increase the bradycardic activities of Timolol.
Timolol Anhydrous
Ginkgo biloba may increase the bradycardic activities of Timolol.
Tiotropium
The therapeutic efficacy of Tiotropium can be decreased when used in combination with Ginkgo biloba.
Tixocortol
The risk or severity of adverse effects can be increased when Tixocortol is combined with Ginkgo biloba.
Tolterodine
The therapeutic efficacy of Tolterodine can be decreased when used in combination with Ginkgo biloba.
Triamcinolone
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Ginkgo biloba.
Trihexyphenidyl
The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Ginkgo biloba.
Trihexyphenidyl Hydrochloride
The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Ginkgo biloba.
Trimethaphan
The therapeutic efficacy of Trimethaphan can be decreased when used in combination with Ginkgo biloba.
Trolamine Salicylate
Ginkgo biloba may increase the anticoagulant activities of Trolamine salicylate.
Tropicamide
The therapeutic efficacy of Tropicamide can be decreased when used in combination with Ginkgo biloba.
Trospium
The therapeutic efficacy of Trospium can be decreased when used in combination with Ginkgo biloba.
Tubocurarine
The therapeutic efficacy of Tubocurarine can be decreased when used in combination with Ginkgo biloba.
Umeclidinium
The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Ginkgo biloba.
Varenicline
The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Varenicline.
Vecuronium
The therapeutic efficacy of Vecuronium can be decreased when used in combination with Ginkgo biloba.
Warfarin
The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Warfarin.
